Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2006, Vol. 107, No. 8, pp. 3295-3302.
Prepublished online as a Blood First Edition Paper on December 27, 2005; DOI 10.1182/blood-2005-07-2730.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-07-2730v1
107/8/3295    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, S. A
Right arrow Articles by Cesarman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, S. A
Right arrow Articles by Cesarman, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 11, 2005
Accepted November 24, 2005

NF-{kappa}B is essential for progression of KSHV- and EBV-infected lymphomas in vivo

Shannon A Keller, Denise Hernandez-Hopkins, Jelena Vider, Vladimir Ponomarev, Elizabeth Hyjek, Elaine J Schattner, and Ethel Cesarman*

Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA
Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Department of Medicine, Division of Hematology and Oncology, Weill Medical College of Cornell University, New York, NY, USA

* Corresponding author; email: ecesarm{at}med.cornell.edu.

Activated NF-{kappa}B is a critical mechanism by which lymphoma cells infected by Epstein-Barr virus (EBV/HHV-4) and Kaposi's sarcoma herpesvirus (KSHV/HHV-8) are protected from apoptotic stress. Selective pharmacological inhibition of constitutive NF-{kappa}B activity induces apoptosis in both KSHV and EBV infected lymphoma cells. In both tumor types, pharmacologic inhibition of NF-{kappa}B in vitro induced identical mitochondrially-mediated apoptotic cascades. Assessment of gene regulation by microarray analysis revealed that inhibition of NF-{kappa}B in tumor cells results in down-regulation of a distinct group of pro-survival genes including cIAP-1, cIAP-2, cFLIP and IL-6. Using EBV and KSHV-associated lymphomas in a murine system, we demonstrate that Bay 11-7082, a selective pharmacological inhibitor of NF-{kappa}B, prevents or delays tumor growth and prolongs disease-free survival. Inhibition of NF-{kappa}B activity and tumor growth responses were further documented using a traceable reporter KSHV-positive cell line and in vivo imaging. These findings indicate that specific NF-{kappa}B regulated survival factors work cooperatively to protect KSHV and EBV infected lymphoma cells from apoptotic stimuli, such that they promote establishment and progression of both KSHV and EBV-associated lymphomas in mice. They also support the use of selective NF-{kappa}B inhibitors in the treatment of herpesvirus-associated lymphomas.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
Y. Etzion, A. Hackett, B. M. Proctor, J. Ren, B. Nolan, T. Ellenberger, and A. J. Muslin
An Unbiased Chemical Biology Screen Identifies Agents That Modulate Uptake of Oxidized LDL by Macrophages
Circ. Res., July 17, 2009; 105(2): 148 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. T. Krug, C. M. Collins, L. M. Gargano, and S. H. Speck
NF-{kappa}B p50 Plays Distinct Roles in the Establishment and Control of Murine Gammaherpesvirus 68 Latency
J. Virol., May 15, 2009; 83(10): 4732 - 4748.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Konrad, E. Wies, M. Thurau, G. Marquardt, E. Naschberger, S. Hentschel, R. Jochmann, T. F. Schulz, H. Erfle, B. Brors, et al.
A Systems Biology Approach To Identify the Combination Effects of Human Herpesvirus 8 Genes on NF-{kappa}B Activation
J. Virol., March 15, 2009; 83(6): 2563 - 2574.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S.-J. Lee, M. Long, A. J. Adler, R. S. Mittler, and A. T. Vella
The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death
J. Leukoc. Biol., January 1, 2009; 85(1): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Guasparri, D. Bubman, and E. Cesarman
EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression
Blood, April 1, 2008; 111(7): 3813 - 3820.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M-Q Du, C M Bacon, and P G Isaacson
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders
J. Clin. Pathol., December 1, 2007; 60(12): 1350 - 1357.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Orbach, J. Rachmilewitz, M. Parnas, J.-H. Huang, M. L. Tykocinski, and M. Dranitzki-Elhalel
CTLA-4 {middle dot} FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals
J. Immunol., December 1, 2007; 179(11): 7287 - 7294.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Zhang, L. Zhi, S. M. Moochhala, P. K. Moore, and M. Bhatia
Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis
J. Leukoc. Biol., October 1, 2007; 82(4): 894 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Zou, J. Kawada, L. Pesnicak, and J. I. Cohen
Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells
J. Virol., September 15, 2007; 81(18): 10029 - 10036.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Stewart, W. Wei, A. Challa, R. J. Armitage, J. R. Arrand, M. Rowe, L. S. Young, A. Eliopoulos, and J. Gordon
CD154 Tone Sets the Signaling Pathways and Transcriptome Generated in Model CD40-Pluricompetent L3055 Burkitt's Lymphoma Cells
J. Immunol., September 1, 2007; 179(5): 2705 - 2712.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Huang, J. Zhao, S. Shen, H. Li, K.-L. He, G.-X. Shen, L. Mayer, J. Unkeless, D. Li, Y. Yuan, et al.
Listeria monocytogenes Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling
Cancer Res., May 1, 2007; 67(9): 4346 - 4352.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sadagopan, N. Sharma-Walia, M. V. Veettil, H. Raghu, R. Sivakumar, V. Bottero, and B. Chandran
Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained NF-{kappa}B Activation during De Novo Infection of Primary Human Dermal Microvascular Endothelial Cells That Is Essential for Viral Gene Expression
J. Virol., April 15, 2007; 81(8): 3949 - 3968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Zhang, L. Zhi, S. Moochhala, P. K. Moore, and M. Bhatia
Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-{kappa}B
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L960 - L971.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Wang, S. Wang, H. Maeng, D. P. Young, O. Prakash, L. E. Fayad, A. Younes, and F. Samaniego
K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis
Blood, March 1, 2007; 109(5): 2174 - 2182.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020